Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Ashler et Manson S.A. (MLAEM.PA)
Bordeaux, FR
Ashler Et Manson functions as a financial intermediary, specializing in the arrangement of loans for both real estate acquisitions and insurance-related purposes. The firm presents a diverse portfolio of financing solutions, offering loans with either fixed or fluctuating interest rates. These options cover various repayment methods, such as installment-based (amortizable) loans and those with a single lump-sum repayment at the end (in fine). Their services also extend to specialized financial instruments like bridge loans and traditional mortgage financing. Additionally, the company provides life insurance products. Ashler Et Manson was established in 2003 and operates from its primary location in Bordeaux, France.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -10.88% | -9.66% | -5.76% | +7.38% | +21.30% | -34.50% | +20.18% | +69.03% | +66.88% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Insurance - Brokers: +8.0%-24.9%
-
EPS growth Insurance - Brokers: +30.1%-100.0%
-
FCF margin FCF growth · Insurance - Brokers: +26.6%+16.5% ★
-
EBIT margin Insurance - Brokers: +19.1%+19.6% ★
-
ROIC Insurance - Brokers: +6.4%+4.2%
-
Share dilution Insurance - Brokers: -0.6%-100.0% ★
-
Debt / EBITDA Net debt/EBITDA · Insurance - Brokers: -0.02×2.27×
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Aymerick Penicaut | Chairman of the Board & CEO | — | male |
| Sylvain Bonnebat | Deputy MD & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MLAEM.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
